Guided Therapeutics Inc (GTHP): Cost of Revenue
$196.0K
Year ended 2025-12-31
$158.0K
Trailing 12 months to 2026-06-30
+34.3%
3-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $196.0K | n/m | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $5.0K | -91.9% | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | $62.0K | -23.5% | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | $81.0K | +32.8% | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | $61.0K | n/a | 2023-03-30, From 2021-01-01 |
| No annual figure between 2011-12-31 and 2021-12-31. | |||
| 2011-12-31 | -$106.0K | n/a | 2012-03-28, From 2011-01-01 |
| 2010-12-31 | $0 | n/a | 2012-03-28, From 2010-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Guided Therapeutics Inc (GTHP) | 2025-12-31 | $196.0K | n/m |
| iTonic Holdings Ltd (ITOC) | 2025-12-31 | $195.7K | +191.9% |
| Positron Corp (POSC) | 2025-12-31 | $2.58M | +177.1% |
| Nexalin Technology, Inc. (NXL) | 2025-12-31 | $61.4K | +67.7% |
| Hongchang International Co., Ltd (HCIL) | 2024-12-31 | $2.69M | +3.0% |
| ADM Tronics Unlimited, Inc. (ADMT) | 2026-03-31 | $1.99M | +10.6% |
| Neuraxis, Inc (NRXS) | 2025-12-31 | $562.9K | +55.5% |
| Nuwellis, Inc. (NUWE) | 2025-12-31 | $3.15M | +2.7% |
| Escalon Medical Corp (ESMC) | 2026-06-30 | $7.17M | +9.7% |
Compare GTHP, ITOC, POSC, NXL side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗